Table 1.
Summary of the different studies that reported the serotype of FMDV along with their prevalence percentage in particular regions.
| Country name | Serotype of FMDV | References |
|---|---|---|
| Pakistan | Study 1: Serotype A = 4.7%, O = 70%, and Asia1 = 25% | (118) |
| Study 2: Serotype A = 13.89%, O = 45.83%, Asia1 = 29.17%, AO = 9.72%, and Asia1+ O = 1.39 | (30) | |
| Study 3: Serotype A = 24.14%, O = 65.52%, and Asia1 = 10.35% | (19) | |
| Serotype A = 65.25%, O = 56.25%, and Asia1 = 20.70% | ||
| Serotype A = 10.35%, O = 37.50%, and Asia1 = 4.60% | ||
| Study 4: Serotype A = 6.60%, O = 20.70%, and Asia1 = 4.60% | (119) | |
| Serotype A = 2.90%, O = 20.40%, and Asia1 = 4.70% | ||
| Serotype A = 31.60%, O = 22.40%, and Asia1 = 4.00% | ||
| Study 5: Serotype A = 21.91%, O = 6.84%, and Asia1 = 71.23% | (120) | |
| India | Study 1: Serotype A = 14%, O = 67%, C = 4%, and Asia1 = 15% | (121) |
| Study 2: Serotype A = 8%, O = 80%, and Asia1 = 12% | (32) | |
| Study 3: Serotype A = 3%, O = 92%, and Asia1 = 5% | (37) | |
| Study 4: Serotype A = 12.27%, O = 64.04%, and Asia1 = 19.87% | (36) | |
| Serotype A = 9.01%, O = 82.59%, and Asia1 = 8.40% | ||
| Egypt | Study 1: Serotype A = 12.28%, O = 80.70%, and SAT2 = 7% | (122) |
| Serotype A = 36.70%, O = 56.96%, and SAT2 = 6.32% | ||
| Study 2: Serotype A = 68.18%, O = 93.82%, and SAT2 = 35.23% | (82) | |
| Iraq | Study 1: Serotype A = 57.60%, and O = 30.70% | (123) |
| Study 2: Serotype A = 12.39%, O = 6.95%, SAT1 = 3.69, and Asia1 = 17.39% | (123) |
Available studies have been illustrated comprehensively.